These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4621955)

  • 1. Survival of hematopoietic and lymphoma colony-forming cells in vivo following the administration of a variety of alkylating agents.
    Valeriote FA; Tolen SJ
    Cancer Res; 1972 Mar; 32(3):470-6. PubMed ID: 4621955
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of antineoplastic agents on tumor cells in vivo and in vitro (literature review)].
    Merkulov MF; Shelaputina ZF; Leskova SG; Belinskiĭ VA; Talipov ASh
    Farmakol Toksikol; 1971; 34(4):490-504. PubMed ID: 4334362
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival of hematopoietic and leukemic colony-forming cells in vivo following the administration of daunorubicin or adriamycin.
    Razek A; Valeriote F; Vietti T
    Cancer Res; 1972 Jul; 32(7):1496-500. PubMed ID: 5030578
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors determining cell killing by chemotherapeutic agents in vivo. II. Melphalan, chlorambucil and nitrogen mustard.
    van Putten LM; Lelieveld P
    Eur J Cancer (1965); 1971 Feb; 7(1):11-6. PubMed ID: 5576726
    [No Abstract]   [Full Text] [Related]  

  • 5. Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers in vitro resistance to alkylating agents in human leukemia cells and in clonogenic mouse hematopoietic progenitor cells.
    Letourneau S; Greenbaum M; Cournoyer D
    Hum Gene Ther; 1996 May; 7(7):831-40. PubMed ID: 8860835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic interactions between cyclophosphamide or melphalan and VP-16 in a human rhabdomyosarcoma xenograft.
    Lilley ER; Rosenberg MC; Elion GB; Colvin OM; Bigner DD; Friedman HS
    Cancer Res; 1990 Jan; 50(2):284-7. PubMed ID: 2295068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute in vivo resistance in high-dose therapy.
    Teicher BA; Ara G; Keyes SR; Herbst RS; Frei E
    Clin Cancer Res; 1998 Feb; 4(2):483-91. PubMed ID: 9516940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
    Nath K; Nelson DS; Putt ME; Leeper DB; Garman B; Nathanson KL; Glickson JD
    PLoS One; 2016; 11(6):e0157125. PubMed ID: 27285585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated mice.
    Down JD; Westerhof GR; Boudewijn A; Setroikromo R; Ploemacher RE
    Bone Marrow Transplant; 1998 Feb; 21(4):327-30. PubMed ID: 9509964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hemopoietic stem cells and antitumoral drugs. 1. Variations of in vitro and in vivo colony forming cells following single dose administration of cyclophosphamide, vinblastine and azathioprine (author's transl)].
    Pannacciulli I; Ghio R; Bogliolo G; Massa G; Saviane A; Bianchi G
    Haematologica; 1976 Dec; 61(4):432-8. PubMed ID: 828607
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions of cytotoxic and anti-inflammatory agents on normal and neoplastic tissue.
    Powles TJ; Frank GJ; Millar JL
    Adv Prostaglandin Thromboxane Res; 1980; 6():587-9. PubMed ID: 7386294
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation of alkylating agents by lonidamine in vivo.
    Teicher BA; Holden SA; Herman TS; Frei E
    Semin Oncol; 1991 Apr; 18(2 Suppl 4):7-10. PubMed ID: 1903216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of stem cell factor on the growth and radiation survival of tumor cells.
    Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
    Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sensitivity of the splenic cells of different mouse strains to the antiproliferative action of alkylating compounds].
    Pukhal'skiĭ AL; Mezhneva AP; Pevnitskiĭ LA
    Biull Eksp Biol Med; 1988 Feb; 105(2):196-8. PubMed ID: 3349150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle phase specificity of antitumor agents.
    Bhuyan BK; Scheidt LG; Fraser TJ
    Cancer Res; 1972 Feb; 32(2):398-407. PubMed ID: 4258018
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
    Phelan ET; Vietti TJ; Valeriote FA; Coulter D
    Anticancer Res; 1981; 1(3):149-54. PubMed ID: 7342853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of some alkylating agents and whole-body ionizing radiation on the formation and realization of immunologic memory].
    Kazarian KA; Fontalin LN; Pevnitskiĭ LA; Solov'ev VV
    Biull Eksp Biol Med; 1971 Nov; 72(11):58-61. PubMed ID: 5002198
    [No Abstract]   [Full Text] [Related]  

  • 18. The mechanisms of action of antitumor compounds.
    Belousova AK
    Natl Cancer Inst Monogr; 1977 Mar; (45):183-93. PubMed ID: 73135
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential effects of melphalan on mouse myeloma (adj. PC-5) and hemopoietic stem cells.
    Ogawa M; Bergsagel DE; McCulloch EA
    Cancer Res; 1971 Dec; 31(12):2116-9. PubMed ID: 5120302
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of antileukemic agents on the respiratory activity of murine lymphocytic Leukemia L1210.
    Goodman MT; Folk RM; Ackerman GA
    J Natl Cancer Inst; 1973 Sep; 51(3):917-28. PubMed ID: 4743561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.